With regulatory requirements looming and a growing desire to prevent counterfeiting, tampering, theft, and diversion, companies must begin to look ...

This week, Joe D’Ambrosio from Clarkston Consulting moderated a panel of industry experts at the most recent CED Biotech Forum.

The Life Sciences industry faces a multitude of challenges and threats moving into 2012, but within each challenge lies great ...

In April 2011, the Food and Drug Administration (FDA) released an update of its strategic priorities, outlining the goals and ...

Over the past decade, in our experience working with Life Sciences companies, we have seen many companies fail to achieve ...